Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing Triple vs Quadruple Therapy for H. Pylori Eradication
NCT04617613Phase 4Completed
- Sponsor
- Al-Azhar University
- Start
- Sep 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of metronidazole in Helicobacter pylori infection (2 arms), sponsored by Al-Azhar University. Primary endpoints: Negative 13-Carbon urea breath test at 1 month and Adverse events at 1 month. Started Sep 2016; status: completed.
02
Drugs
metronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04617613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04617613.